Skip to content

Treatment of psoriasis with fumaric acid esters: results of a prospective multicentre study: German Multicentre Study

Treatment of psoriasis with fumaric acid esters: results of a prospective multicentre study: German Multicentre Study 1

4: Mrowietz U, Christophers E, Altmeyer P. Treatment of psoriasis with fumaric acid esters: results of a prospective multicentre study. German Multicentre Study. Abstract: Fumaric acid esters (FAE) are small molecules with immunomodulating, anti-inflammatory, and anti-oxidative effects. The results of these studies cannot be easily pooled given that there is heterogeneity in FAE formulations, treatment duration, and treatment outcomes. A German prospective, multicenter study among 363 psoriasis patients treated with FAE plus phototherapy reported favorable effectiveness and short-term safety up to 1 year for the combination treatment. Fumaric acid esters (FAE) are chemical compounds derived from the unsaturated dicarbonic acid fumaric acid. In 1994, Fumaderm an enteric-coated tablet containing DMF and calcium, magnesium, and zinc salts of MEF was approved for the treatment of psoriasis in Germany and since then has become the most commonly used systemic therapy in this country. Treatment of psoriasis with fumaric acid esters: Results of a prospective multicentre study.

Treatment of psoriasis with fumaric acid esters: results of a prospective multicentre study: German Multicentre Study 2The German Fumaric Acid Ester Consensus Conference. Altmeyer, P. Treatment of psoriasis with fumaric acid esters: results of a prospective multicentre study. Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis. This study collected data on the safety and efficacy of fumaric acid esters (FAE; Fumaderm) in the long-term treatment of psoriasis. Treatment of psoriasis with fumaric acid esters: results of a prospective multicentre study. 34Mrowietz, U. et al, Treatment of psoriasis with fumaric acid esters: Results of a prospective multicentre study. German Multicentre Study. Br J Dermatol. 1998;138:456 460.

Fumaric acid esters are thought to improve psoriasis by altering leukocyte, keratinocyte, and/or endothelial functions. Herne, Germany) is the only FAE registered for oral treatment of psoriasis. Mrowietz U, Christophers E, Altmeyer P. Treatment of psoriasis with fumaric acid esters: results of a prospective multicentre study. German multicentre study. Learn about the potential benefits of Fumitory including contraindications, adverse reactions, toxicology, pharmacology and historical usage. In traditional medicine, the plant has been used to treat eczema and other dermatologic conditions. 16 F. officinalis is approved in Germany for the colicky pain affecting the gallbladder and biliary system, in addition to the GI tract. Treatment of psoriasis with fumaric acid esters: results of a prospective multicentre study.

References In Fumaric Acid Esters

Mono-Ethyl fumarate (fumaric acid monoethyl ester, monoethyl fumarate) was used in the preparation of photo-crosslinkable macromers. The German Fumaric Acid Ester Consensus Conference. Treatment of psoriasis with fumaric acid esters: results of a prospective multicentre study. Much like vitamin D, fumaric acid is formed by the body, in the skin, during exposure to sunlight. As a result, some health care providers recommend fumaric acid to help treat psoriasis and other skin conditions. Mrowietz U, Christophers E, Altmeyer P. Treatment of psoriasis with fumaric acid esters: results of a prospective multicentre study. German multicentre study. Fumaric acid esters (FAE) are used in Germany as a first-line systemic treatment for chronic plaque psoriasis, with proven efficacy and low toxicity. Treatment of psoriasis with fumaric acid esters: results of a prospective multicentre study. The aim of the present prospective multicentre study was to investigate further the efficacy and safety of FAE therapy in a large number of patients with severe psoriasis vulgaris. Physician Global Assessment (PGA) and Psoriasis Area and Severity Index (PASI): Why do both? A systematic analysis of randomized controlled trials of biologic agents for moderate to severe plaque psoriasis. Efficacy and safety profile of fumaric acid esters in oral long-term therapy with severe treatment refractory psoriasis vulgaris. 6Mrowietz, U.E., Christophers, E., Altmeyer, P. Treatment of psoriasis with fumaric acid esters: results of a prospective multicentre study. German Multicentre Study.

Dimethylfumarate Inhibits Tumor-necrosis-factor-induced Cd62e Expression In An Manner